AFL · 10-Q · 2026Q3

AFLAC INC

Filed 2026-11-05 · Financials · View original filing on EDGAR

Everything AFL's SEC filings said, ranked

Ranked Events

• Net Income and ProfitabilityImportance 71 · Surprise 82
  Net earnings were $303 million, or $0.61 per diluted share, in the third quarter of 2026, compared with $1.6 billion, or $3.08 per diluted share, in the third quarter of 2025. Third-quarter 2026 earnings included $1.1…
• Revenue Performance and MixImportance 66 · Surprise 74
  Total revenues were $3.3 billion in the third quarter of 2026, down from $4.7 billion in the third quarter of 2025, primarily because net investment losses of $1.1 billion replaced net investment gains of $275 million.…
• Aflac Japan Segment PerformanceImportance 59 · Surprise 48
  Aflac Japan’s third-quarter 2026 benefits-and-claims ratio to total premiums increased to 49.2% from 39.3%, primarily because annual cash flow assumption updates generated lower reserve remeasurement gains. The company…
• Investment Portfolio RepositioningImportance 49 · Surprise 32
  At September 30, 2026, Aflac held $100.433 billion of investments and cash, down from $103.760 billion at December 31, 2025; total investments were $94.810 billion, including $70.559 billion in Aflac Japan, $15.901…
• Aflac U.S. Segment PerformanceImportance 46 · Surprise 56
  Aflac U.S. pretax adjusted earnings increased 31.5% in the third quarter of 2026 and 9.4% in the first nine months, while total adjusted revenues rose 3.1% and 3.0%, respectively. Third-quarter net earned premiums…
• Corporate Other Earnings DeclineImportance 45 · Surprise 64
  Corporate and other pretax adjusted earnings declined 53.0% in the first nine months of 2026, as adjusted revenues fell 6.2% and adjusted expenses increased 13.2%. Nine-month adjusted net investment income decreased…
• Guidance / OutlookImportance 42 · Surprise 24
  For full-year 2026, the Company expects Aflac Japan’s benefit ratio to be slightly below its 60%–63% range. It expects Aflac U.S.’s full-year 2026 benefit ratio to be below its 48%–52% range. The filing does not…
• Income Tax Rate ChangesImportance 39 · Surprise 50
  The combined U.S. and Japanese effective tax rate was 39.6% for the third quarter of 2026, compared with 17.8% in the third quarter of 2025. For the first nine months, the effective rate was 21.1% in 2026 versus 23.4%…
• Capital Return ProgramImportance 38 · Surprise 24
  Aflac Incorporated repurchased $2.8 billion of common shares, or 24.3 million shares, during the first nine months of 2026. At September 30, 2026, 90.0 million shares remained authorized for repurchase. The company had…
• FX / Currency HeadwindsImportance 36 · Surprise 40
  For the three months ended September 30, 2026, Aflac Japan total adjusted revenues declined 0.3% in yen including currency changes and 1.8% excluding currency changes; for the nine months, they fell 3.1% both including…
• Product Launch and TransitionImportance 34 · Surprise 42
  Aflac Japan’s portfolio centers on third-sector cancer, medical and other health products, which the company expects to remain important as pressure on Japan’s healthcare system drives a continued need for these…
• Commercial Real Estate Credit RiskImportance 32 · Surprise 24
  Aflac’s transitional real estate loans and commercial mortgage loans are collateralized by commercial real estate, including office properties, and some loans were in default on interest or maturity payments. The…
• Aflac Japan Sales TrendsImportance 30 · Surprise 40
  Aflac Japan’s new annualized premium sales in yen declined 4.0% in the third quarter of 2026, while nine-month sales increased 16.1%; the comparable reported dollar changes were a decline of 11.2% for the quarter and…
• Investment Portfolio Unrealized LossesImportance 25 · Surprise 6
  At September 30, 2026, Aflac’s 10 largest unrealized loss positions included a $5.017 billion loss on Japan National Government securities, with $31.351 billion amortized cost and $26.334 billion fair value. The other…
• Market Demand TrendsImportance 23 · Surprise 24
  Aflac says continued cost pressure on Japan’s health care system is expected to increase future demand for third-sector insurance products, including cancer, medical, and other health coverage. The Company expects…
• Aflac U.S. Sales TrendsImportance 18 · Surprise 14
  Aflac U.S. new annualized premium sales increased 3.5% in the third quarter and 3.1% in the first nine months of 2026. Growth in both periods was primarily driven by group products. Disability products represented…
• Interest Rate EnvironmentImportance 13 · Surprise 6
  Aflac reported that higher U.S. dollar and Japanese yen interest rates contributed to the increase in Aflac Japan’s new money yield for the nine months ended September 30, 2026. The Company also said its U.S.…
• Aflac Japan Distribution ChannelsImportance 13 · Surprise 6
  Aflac Japan distributes products through independent corporate and individual agencies, affiliated corporate agencies, and banks. In the third quarter of 2026, affiliated corporate agencies, including Japan Post Group,…

Revenue by Product (in millions)

Revenue by Geography (in millions)